The first ProPhase Labs trade was made in Q4 2013.
Since then Ken Griffin bought shares 26 more times and sold shares on 29 occasions. The investor completely sold their stake between Q2 2024 and Q3 2024.
Avg closing price
Price range
Sold -3.8 Thousand shares
Q3 2024
Avg closing price
$2.83
Price range
$2.16
-
$4.06
Sold 43.9% shares (-2.98 Thousand shares)
Q2 2024
Avg closing price
$5.24
Price range
$4.18
-
$7.35
New holding (+6.77 Thousand shares)
Q1 2024
Avg closing price
$5.06
Price range
$4.47
-
$6.47
Sold -3.27 Thousand shares
Q4 2023
Avg closing price
$4.56
Price range
$4.35
-
$5.10
Increased shares by 511.6% (+2.74 Thousand shares)
Q3 2023
Avg closing price
$5.86
Price range
$4.23
-
$7.53
Sold 97.8% shares (-24.3 Thousand shares)
Q2 2023
Avg closing price
$8.14
Price range
$7.15
-
$9.78
Increased shares by 128.1% (+14 Thousand shares)
Q1 2023
Avg closing price
$8.06
Price range
$6.62
-
$9.57
New holding (+10.9 Thousand shares)
Q4 2022
Avg closing price
$10.80
Price range
$8.78
-
$12.53
Sold -17.9 Thousand shares
Q2 2022
Avg closing price
$8.79
Price range
$6.52
-
$13.24
Sold 37.0% shares (-10.5 Thousand shares)
Q1 2022
Avg closing price
$6.95
Price range
$6.20
-
$7.87
Increased shares by 30.7% (+6.69 Thousand shares)
Q4 2021
Avg closing price
$6.22
Price range
$5.13
-
$7.89
Increased shares by 37.2% (+5.9 Thousand shares)
Q3 2021